Abstract

Background: Pregnant women with type 1 diabetes (T1D) are at high risk of multiple pregnancy-related complications associated with poor glycemic control and pathologically raised insulin resistance that continuously increases throughout the pregnancy. The use of continuous glucose monitoring (CGM) devices significantly reduces the incidence of large-for-gestational-age (LGA) newborns in individuals with T1D.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call